ArticleEJNMMI radiopharmacy and chemistry2024

Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology.

Panagiotis Kanellopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.